Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Potential crawled time : 12:01 save search
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
Published: 2020-12-22 (Crawled : 12:01) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 3.05%
H: 1.28%
C: -2.74%
diabetes obesity license oxytocin insulin potential
Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
Published: 2020-12-14 (Crawled : 12:01) - globenewswire.com
ARVN | $34.3 2.54% 2.48% 800K
|
Health Technology
|
| O: 129.34%
H: 9.27%
C: -14.95%
potential
EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a Potential Six-month Treatment of Wet Age-related Macular Degeneration
Published: 2020-12-03 (Crawled : 12:01) - globenewswire.com
EYPT | $17.49 -16.48% -19.73% 4.1M
|
Health Technology
|
| O: -1.89%
H: 3.81%
C: -1.1%
positive results positive results eye macular treatment potential
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.